Although HER3 itself does not cause tumorigenesis, the HER2:HER3 heterodimer has the highest transforming capacity among all possible EGFR family dimers, and the superior oncogenic capacity of the dimer makes HER3 critical for HER2-mediated tumorigenesis in breast cancer [42, 43]. This evidence concerns the gene EGFR and breast cancer.